Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OMER Omeros Corp
- Stocks
- Healthcare
- NASDAQ: OMER
Price (delayed)
$3.495
Market cap
$204.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.66
Enterprise value
$615.57M
Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous
Highlights
The debt has declined by 12% year-on-year
The net income has contracted by 26% YoY but it has grown by 2.4% from the previous quarter
OMER's equity has dropped by 199% year-on-year and by 17% since the previous quarter
Omeros's quick ratio has plunged by 82% YoY and by 42% from the previous quarter
Key stats
What are the main financial stats of OMER
Market
Valuations
Earnings
Shares outstanding
58.59M
Market cap
$204.78M
Enterprise value
$615.57M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$165.19M
Net income
-$153.09M
EBIT
-$132.99M
EBITDA
-$131.96M
Free cash flow
-$143.01M
Per share
Balance sheet
Liquidity
EPS
-$2.66
EPS diluted
-$2.66
Free cash flow per share
-$2.46
Book value per share
-$3.68
Revenue per share
$0
TBVPS
$4.05
Total assets
$235.16M
Total liabilities
$448.71M
Debt
$415.05M
Equity
-$213.55M
Working capital
$12.96M
Debt to equity
-1.94
Current ratio
1.16
Quick ratio
0.71
Net debt/EBITDA
-3.11
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-51.8%
Return on equity
N/A
Return on invested capital
-20.4%
Return on capital employed
-87.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OMER stock price
How has the Omeros stock price performed over time
Intraday
3.4%
1 week
8.54%
1 month
10.6%
1 year
-10.15%
YTD
-64.63%
QTD
-57.48%
Financial performance
How have Omeros's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$165.19M
Net income
-$153.09M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 26% YoY but it has grown by 2.4% from the previous quarter
Omeros's operating income has increased by 2.4% from the previous quarter
Price vs fundamentals
How does OMER's price correlate with its fundamentals
Growth
What is Omeros's growth rate over time
Valuation
What is Omeros stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has declined by 35% year-on-year
OMER's equity has dropped by 199% year-on-year and by 17% since the previous quarter
Efficiency
How efficient is Omeros business performance
The ROA has plunged by 96% YoY and by 14% from the previous quarter
Omeros's ROIC has plunged by 79% YoY and by 11% from the previous quarter
Dividends
What is OMER's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OMER.
Financial health
How did Omeros financials performed over time
The total assets is 48% less than the total liabilities
Omeros's quick ratio has plunged by 82% YoY and by 42% from the previous quarter
The current ratio has plunged by 76% YoY and by 31% from the previous quarter
OMER's equity has dropped by 199% year-on-year and by 17% since the previous quarter
Omeros's debt to equity has soared by 71% YoY and by 16% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.